Krane Funds Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $567K | Buy |
20,234
+2,680
| +15% | +$71.3K | 0.02% | 114 |
|
|
2025
Q4 | $437K | Sell |
17,554
-2,026
| -10% | -$51.1K | 0.01% | 116 |
|
|
2025
Q3 | $476K | Sell |
19,580
-2,962
| -13% | -$73.1K | 0.01% | 94 |
|
|
2025
Q2 | $546K | Buy |
22,542
+3,625
| +19% | +$84.5K | 0.02% | 50 |
|
|
2025
Q1 | $479K | Buy |
18,917
+1,781
| +10% | +$46.6K | 0.01% | 53 |
|
|
2024
Q4 | $455K | Sell |
17,136
-1,514
| -8% | -$41.1K | 0.02% | 49 |
|
|
2024
Q3 | $540K | Sell |
18,650
-2,009
| -10% | -$58.6K | 0.02% | 43 |
|
|
2024
Q2 | $578K | Sell |
20,659
-1,172
| -5% | -$32.3K | 0.02% | 35 |
|
|
2024
Q1 | $602K | Buy |
21,831
+1,590
| +8% | +$44.1K | 0.02% | 35 |
|
|
2023
Q4 | $583K | Buy |
20,241
+1,163
| +6% | +$35.2K | 0.02% | 45 |
|
|
2023
Q3 | $633K | Buy |
19,078
+2,162
| +13% | +$76.5K | 0.03% | 40 |
|
|
2023
Q2 | $620K | Buy |
16,916
+619
| +4% | +$24.1K | 0.03% | 38 |
|
|
2023
Q1 | $681K | Buy |
16,297
+1,565
| +11% | +$67.6K | 0.03% | 43 |
|
|
2022
Q4 | $755K | Buy |
+14,732
| New | +$706K | 0.03% | 38 |
|
|
2022
Q3 | – | Sell |
-5,347
| Closed | -$280K | – | 232 |
|
|
2022
Q2 | $280K | Sell |
5,347
-2,742
| -34% | -$140K | 0.01% | 179 |
|
|
2022
Q1 | $419K | Buy |
8,089
+1,463
| +22% | +$75.9K | 0.02% | 194 |
|
|
2021
Q4 | $391K | Sell |
6,626
-2,433
| -27% | -$121K | 0.01% | 185 |
|
|
2021
Q3 | $390K | Buy |
+9,059
| New | +$401K | 0.01% | 233 |
|
|
2020
Q4 | – | Sell |
-11,238
| Closed | -$391K | – | 321 |
|
|
2020
Q3 | $391K | Buy |
+11,238
| New | +$394K | 0.02% | 139 |
|
Other funds holding PFE
VCM
VPM
